FDA-M-CERSI “Collaborating to Advance Health Equity for Diabetes and Chronic Kidney Disease” – February 10, 2021
FDA (OMHHE) and the University of Maryland-CERSI invite us to attend the Virtual Workshop Collaborating to Advance Health Equity for Diabetes and Chronic Kidney Disease
Date: Wednesday, February 10, 2021 10:00 am – 3:00 pm ET
The workshop aims to advance attendees’ understanding of the following:
- Leveraging patient experience data and community/system approaches to inform care, drug development and overall research agenda to improve patient outcomes and reduce health inequities for diverse communities with diabetes and chronic kidney disease (CKD).
- Explore barriers to diversity in clinical trials for CKD and diabetes and strategies to improve diversity in clinical trials.
- Utilization of real-world data to inform strategies and decision making on the management of diabetes and CKD.
Registration is Free Hosted by the Food and Drug Administration and the University of Maryland Center for Excellence in Regulatory Science and Innovation (M-CERSI)